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Introduction
Epidemic pleurodynia is characterized by fever and sharp, 
spasmodic pain in the chest or upper abdomen. It was 
first described in 1872 by Daae and Homann during 
an outbreak of “acute rheumatism spread by contagion” 
in Norway,1 and was best known as Bornholm disease 
after a similar outbreak on the island of Bornholm in 
Denmark.2 The etiology of the disease was not established 
until 1949 when coxsackievirus B was identified as the 
causative agent.3,4 Other agents subsequently implicated 
in outbreaks of pleurodynia included echovirus5–9 and 
Short Communication
Epidemic Pleurodynia Caused by Coxsackievirus B3 at 
a Medical Center in Northern Taiwan
Wan-Ting Huanga,b, Ping-Ing Leea,b*, Luan-Ying Changa,b, Chuan-Liang Kaoc,d, 
Li-Min Huanga,b, Chun-Yi Lua,b, Jong-Ming Chena,b,c, Chin-Yun Leea,b
aDepartment of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
bDepartment of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan.
cDepartment of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
dGraduate Institute of Medical Technology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Epidemic pleurodynia is seldom reported in Southeast Asia and there has been no report from Taiwan. 
We conducted a retrospective chart review of children ≤ 18 years of age in the National Taiwan University 
Hospital from January 1 to December 31, 2005. Epidemic pleurodynia was defined as an acute illness 
characterized by sharp localized pain over the chest or upper abdomen. Patients with known heart dis-
eases or pulmonary consolidations were excluded. In total, 28 patients met the case definition of epidemic 
pleurodynia. Coxsackievirus B3 (CB3) was isolated in 15 (60%) of the 25 throat swab specimens. Four 
(14%) of the 28 patients presented chest wall tenderness and only one (6%) of the 18 patients tested had an 
elevated creatinine kinase level. Twenty-one (75%) of the 28 patients described pleuritic chest pains and 10 
(45%) of the 22 chest radiographies exhibited pulmonary infiltrates or pleural effusions. Six patients were 
observed with tonsillar exudates and one was confirmed to have a CB3 urinary tract infection. The clinical 
features and radiological findings suggest that CB3-associated epidemic pleurodynia might be a disease 
of the pleura and occasionally spreads to nearby tissues, resulting in chest wall myositis, pulmonary infil-
trates and myopericarditis.
KEYWORDS: chest pain, coxsackievirus B3, epidemic pleurodynia, exudative tonsillitis, pleuritis
516
W.T. Huang, et al
coxsackievirus A.10,11 Classical textbook descriptions of 
this disease usually attribute the illness to a disorder of the 
muscle, but not the pleura or peritoneum.1
Reports of outbreaks of pleurodynia come primarily 
from Europe and North America. There are nearly no reports 
from Southeast Asia. In 2005, we noticed an increased 
number of pediatric patients diagnosed with epidemic 
pleurodynia. Clinical features of the patients involved did 
not conform to the common belief that epidemic pleuro-
dynia was a muscle disorder. This report describes clinical 
features that may shed light on the pathophysiology of 
epidemic pleurodynia.
Methods
A retrospective chart review of patients aged ≤ 18 years at 
the Department of Pediatrics, National Taiwan University 
Hospital, was conducted from January 1 to December 31, 
2005. Epidemic pleurodynia was defined as an acute ill-
ness characterized by sharp localized pain over the chest 
or upper abdomen, with or without fever (body tempera-
ture ≥ 38°C). Those with a history of underlying heart dis-
eases and with radiological findings showing an obvious 
pneumonia with consolidation were excluded. For each 
case, the duration of fever and chest pain, and the pres-
ence of other associated symptoms were recorded.
Laboratory investigations included complete blood 
count with leukocyte differentials, creatinine kinase (CK) 
and its myocardial isoenzyme (CK-MB), troponin I, aspartate 
aminotransferase, electrocardiogram and chest radiography. 
Throat swabs, rectal swabs, stools and body fluid speci-
mens were sent for virus isolation. Samples were inocu-
lated into human embryonic fibroblasts (MRC-5), rhesus 
monkey kidney (LLC-MK2), laryngeal carcinoma (HEp-2) 
and human rhabdomyosarcoma cell cultures. When the 
enteroviral cytopathic effect involved more than 50% of 
the cell monolayer, the cells were scraped and an indirect 
immunofluorescence assay employing a monoclonal anti-
body (Chemicon International Inc., Temecula, CA, USA) 
was performed for enterovirus typing.
Results
Of the 28 patients with a clinical diagnosis of epidemic 
pleurodynia, 6 (21%) were hospitalized. Viral isolation was 
attempted from 25 children. Of the 16 (64%) children 
who tested positive for enterovirus; 15 were identified as 
coxsackievirus B3 (CB3), whereas the remaining one isolate 
could not be typed using indirect immunofluorescence 
assay. The isolation rate of specimens from different sites 
was 60% (15/25) for throat swabs, 33% (1/3) for rectal swabs, 
100% (1/1) for stool samples and 100% (1/1) for urine.
The Table summarizes the clinical and laboratory char-
acteristics of the 28 patients with epidemic pleurodynia. 
For the 28 patients, the median duration of chest pain 
was 4.5 days (range, 1–45 days), 21 (75%) described the 
pain as having “pleuritic” characteristics, defined as a sharp 
pain that may be aggravated during a deep breath and 
that may limit chest wall movement, and four (14%) pre-
sented chest wall tenderness. Other associated symptoms 
and signs observed included fever (median duration = 3 days; 
range, 1–11 days), upper airway symptoms, gastrointestinal 
symptoms, headache, oral ulcers and skin rash (Table).
Blood tests were performed on 18 patients. Only one 
girl, aged 17 years, had an elevated serum CK value of 
211 U/L (normal range, ≤ 167 U/L for females) and her 
chest radiography showed neither pulmonary infiltrates 
nor pleural effusions. Among the 22 patients that had 
chest radiographic examinations, localized or diffuse pul-
monary infiltrates were observed in 10 (45%) patients 
(Figure) and pleural effusions were observed in three 
(14%) patients. Electrocardiograms were performed on 
11 patients and were found to be abnormal in three (27%) 
patients, which included ST-T segment elevation at lead 
I–II and V2–6 (n = 1), inverted T wave at lead V1–3 (n = 1), 
and prolonged PR and QTc intervals (n = 1).
Five (18%) of the 28 children experienced acute comor-
bid illness, including group A streptococcal tonsillitis, acute 
otitis media, myocarditis, orchitis and CB3-associated uri-
nary tract infection. The patient with a clinical diagnosis 
of CB3 urinary tract infection was a boy aged 14 years 
who had proteinuria and microscopic hematuria (35–50 
red blood cells observed per high power field). His urine 
culture yielded CB3 instead of bacteria.
Discussion
Although outbreaks of epidemic pleurodynia have been 
reported from different parts of the world since its first 
description in Scandinavia as Bornholm disease,12,13 this is 
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the first acknowledged incident in Taiwan. Asia, especially 
the southeastern region, has had fewer documented cases 
of epidemic pleurodynia.13 It is likely that the disease 
might have escaped detection because some countries 
lack provisions for the appropriate virological tests. A cor-
rect and prompt recognition of the disease during en-
demic seasons curtails unnecessary usage of antibiotics 
and investigations.14 In addition to the typical sudden onset 
of severe “stabbing” pain with pleuritic characteristics 
over the lower chest or upper abdomen after an incuba-
tion period of 2–5 days, minor constitutional symptoms 
have also been described. In our study, 36% of the patients 
described having headaches, 61% had upper airway symp-
toms, and 39% had gastrointestinal symptoms. The short 
course and rare occurrence of complications of epidemic 
pleurodynia helped to differentiate it from other less 
benign conditions.14–16
Epidemic pleurodynia is generally caused by coxsack-
ievirus B, but less frequently results from echovirus sero-
types 1, 6, 8, 9 and 19,5–9 and from group A coxsackievirus 
serotypes 4, 6, 9 and 10.10,11 Enteroviral isolation is more 
likely to be successful from feces during the acute phase of 
the illness.13,17 A retrospective study of non-polio entero-
viruses showed that stool cultures were positive for non-
polio enteroviruses in 97% of clinical specimens, followed 
by throat swab cultures in 67% of clinical specimens.17 
The isolation rate of throat swab cultures in our study 
was 60%, which was comparable with reported viral isola-
tion rates of 45–52% in previous outbreaks of epidemic 
pleurodynia.3,7,13,14
Since more than half of our patients were confirmed 
to have CB3 infection, it may be concluded that CB3 is 
responsible for this epidemic. Surveillance data from 
the Taiwan Centers for Disease Control also showed 
that from January 1 through to December 31, 2005, CB3 
was the most common subtype, accounting for 28% of all 




 0–4 3 (11)
 5–9 15 (53)
 10–18 10 (36)
Sex
 Male 19 (68)
 Female 9 (32)
Chronic comorbid illness 0 (0)
Symptoms and signs
 Fever 24 (86)
 Chest pain with pleuritic characteristicsa 21 (75)
 Upper airway symptomsb 17 (61)
 Gastrointestinal symptomsc 11 (39)
 Headache 10 (36)
 Tonsillar exudates 6 (21)
 Chest wall tenderness 4 (14)
 Oral ulcer 2 (7)
 Skin rash 1 (4)
Abnormal leukocyte countd (n = 18) 4 (22)
Abnormal CK valuee (n = 16) 1 (6)
Abnormal AST valuef (n = 11) 0 (0)
Abnormal electrocardiogramg (n = 11) 3 (27)
Infiltrates or pleural effusions on chest 10 (45)
 radiography (n = 22)
aDefined as sharp pain with breathing that may limit the chest wall 
movement; binclude runny nose, cough, or sore throat; cinclude nau-
sea, vomiting, or loose stools; dleukocyte count < 4,000/μL (n = 1) 
or > 11,000/μL (n = 3); eCK > 190 U/L (males) or CK > 167 U/L 
(females); fAST > 40 U/L; gST-T segment elevation at lead I–II and 
V2–6 (n = 1), inverted T wave at lead V1–3 (n = 1), and prolonged PR 
and QTc intervals (n = 1). AST = aspartate aminotransferase; CK = 
creatinine kinase.
Figure. Posterior-anterior view of chest radiography showing 
bilateral interstitial infiltrates in a 6-year-old girl with right chest 
pain that could be aggravated by deep breathing. The thoracic 
vertebrae curved to the right side. The throat swab yielded the 
growth of coxsackievirus B3.
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enterovirus isolates.18 Coxsackievirus B is known to cause 
acute central nervous system infections, exanthems, acute 
respiratory diseases, myositis, myopericarditis and neo-
natal sepsis.1 Clinical manifestations observed in this 
study, such as oral ulcers and exanthems, may also be seen 
in some other types of enterovirus infections. However, 
tonsillar exudates and urinary tract infections have been 
rarely described in enterovirus infections. To the best of 
our knowledge, this study may be the first to demonstrate 
the clear association between CB3 and both exudative 
tonsillitis and urinary tract infection.
Although many authors have reported that epidemic 
pleurodynia is a disease of the muscle instead of the 
pleura or peritoneum,1,15,19 only one of the 18 patients 
tested in the present study had elevated serum aspartate 
aminotransferase or CK values. In addition, only a small 
proportion of our patients had chest wall tenderness, and 
none of them had other features that may characterize 
myositis of the chest wall, such as chest wall redness and 
swelling. More patients had chest films showing either 
localized or diffuse pulmonary infiltrates, as well as a small 
amount of pleural effusion. The majority of patients 
clearly stated that their chest pain could be aggravated by 
taking a deep breath, suggesting the presence of pleuritis. 
These findings suggest that CB3-induced epidemic pleu-
rodynia is a disease mainly of the pleura. The inflamma-
tory process may occasionally spread to nearby tissues, 
resulting in chest wall myositis, pulmonary infiltrates and 
myopericarditis.
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